BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Trafford AM, Parisi R, Kontopantelis E, Griffiths CEM, Ashcroft DM. Association of Psoriasis With the Risk of Developing or Dying of Cancer: A Systematic Review and Meta-analysis. JAMA Dermatol 2019;155:1390-403. [PMID: 31617868 DOI: 10.1001/jamadermatol.2019.3056] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 28.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Frost J, Bowcock A, Zhang W. Canonical and Interior Circular RNAs Function as Competing Endogenous RNAs in Psoriatic Skin. Int J Mol Sci 2021;22:5182. [PMID: 34068434 DOI: 10.3390/ijms22105182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Marley J, Nicholl BI, Macdonald S, Mair FS, Jani BD. Associations between long-term conditions and upper gastrointestinal cancer incidence: A prospective population-based cohort of UK Biobank participants. J Comorb 2021;11:26335565211056136. [PMID: 34820338 DOI: 10.1177/26335565211056136] [Reference Citation Analysis]
3 Mcgurk KA, Kasapi M, Ware JS. Effect of taurine administration on symptoms, severity, or clinical outcome of dilated cardiomyopathy and heart failure in humans: a systematic review. Wellcome Open Res 2022;7:9. [DOI: 10.12688/wellcomeopenres.17505.3] [Reference Citation Analysis]
4 Mcgurk KA, Kasapi M, Ware JS. Effect of taurine administration on symptoms, severity, or clinical outcome of dilated cardiomyopathy and heart failure in humans: a systematic review. Wellcome Open Res 2022;7:9. [DOI: 10.12688/wellcomeopenres.17505.1] [Reference Citation Analysis]
5 Pillai A, Valero C, Zanoni D, Navas K, Morris Q, Ganly I, Patel SG. Prognostic impact of autoimmune disease in oral cavity squamous cell carcinoma. Journal of Surgical Oncology. [DOI: 10.1002/jso.27017] [Reference Citation Analysis]
6 Patel S, Kumthekar A. Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice. Rheumatol Ther 2021. [PMID: 34797530 DOI: 10.1007/s40744-021-00397-7] [Reference Citation Analysis]
7 Alali Z, Al Ashour BH, Alrefaee M. Hodgkin's Lymphoma in the Context of Psoriasis Vulgaris Treated With Immunosuppressive Therapy: A Case Report and Review of Literature. Cureus 2021;13:e19490. [PMID: 34912631 DOI: 10.7759/cureus.19490] [Reference Citation Analysis]
8 Fu Y, Lee CH, Chi CC. Association of psoriasis with colorectal cancer. J Am Acad Dermatol 2021;85:1429-36. [PMID: 33011316 DOI: 10.1016/j.jaad.2020.09.050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Gong K, Guo W, Du K, Wang F, Li M, Guo J. Mechanism of Huoluo Xiaoling Dan in the Treatment of Psoriasis Based on Network Pharmacology and Molecular Docking. Evid Based Complement Alternat Med 2022;2022:7053613. [PMID: 35265149 DOI: 10.1155/2022/7053613] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Trafford AM, Parisi R, Rutter MK, Kontopantelis E, Griffiths CEM, Ashcroft DM; Global Psoriasis Atlas (GPA). Concordance and timing in recording cancer events in primary care, hospital and mortality records for patients with and without psoriasis: A population-based cohort study. PLoS One 2021;16:e0254661. [PMID: 34280213 DOI: 10.1371/journal.pone.0254661] [Reference Citation Analysis]
11 Daugherty TT, Swerlick RA. Clinical context for cancer risk of immunosuppressive agents used in dermatology. Dermatol Ther 2021;34:e14433. [PMID: 33084077 DOI: 10.1111/dth.14433] [Reference Citation Analysis]
12 Mishra S, Charan M, Shukla RK, Agarwal P, Misri S, Verma AK, Ahirwar DK, Siddiqui J, Kaul K, Sahu N, Vyas K, Garg AA, Khan A, Miles WO, Song JW, Bhutani N, Ganju RK. cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment. J Exp Clin Cancer Res 2022;41:54. [PMID: 35135586 DOI: 10.1186/s13046-021-02221-0] [Reference Citation Analysis]
13 Ou J, Zhang J, Abdulhay E. Data Mining and Meta-Analysis of Psoriasis Based on Association Rules. Journal of Healthcare Engineering 2022;2022:1-11. [DOI: 10.1155/2022/9188553] [Reference Citation Analysis]
14 Lambert JLW, Segaert S, Ghislain PD, Hillary T, Nikkels A, Willaert F, Lambert J, Speeckaert R. Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 2). J Eur Acad Dermatol Venereol 2020;34:1914-23. [PMID: 32791572 DOI: 10.1111/jdv.16683] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Pillai A, Valero C, Navas K, Morris Q, Patel SG. Peripheral blood values as predictors of autoimmune status in oral cavity squamous cell carcinoma. Transl Oncol 2021;14:101220. [PMID: 34521033 DOI: 10.1016/j.tranon.2021.101220] [Reference Citation Analysis]
16 Vellaichamy G, Townsend SM, Lyons AB, Hamzavi IH. T-cell/histiocyte-rich large B-cell lymphoma in a 27-year-old with hidradenitis suppurativa, psoriasis, and vitiligo: Implications for screening. JAAD Case Rep 2020;6:1252-3. [PMID: 33294556 DOI: 10.1016/j.jdcr.2020.08.032] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Polesie S, Gillstedt M. Psoriasis and risk of cutaneous melanoma: A retrospective, comparative, registry-based cohort study. J Am Acad Dermatol 2021:S0190-9622(21)00244-9. [PMID: 33529701 DOI: 10.1016/j.jaad.2021.01.084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Mcgurk KA, Kasapi M, Ware JS. Effect of taurine administration on symptoms, severity, or clinical outcome of dilated cardiomyopathy and heart failure in humans: a systematic review. Wellcome Open Res 2022;7:9. [DOI: 10.12688/wellcomeopenres.17505.2] [Reference Citation Analysis]
19 Souto EB, de Souza ALR, Dos Santos FK, Sanchez-Lopez E, Cano A, Zielińska A, Staszewski R, Karczewski J, Gremião MPD, Chorilli M. Lipid Nanocarriers for Hyperproliferative Skin Diseases. Cancers (Basel) 2021;13:5619. [PMID: 34830774 DOI: 10.3390/cancers13225619] [Reference Citation Analysis]
20 Asfour L, Yiu ZZN, Warren RB. How is safety of dermatology drugs assessed: trials, registries, and spontaneous reporting. Expert Opin Drug Saf 2020;19:449-57. [PMID: 32228187 DOI: 10.1080/14740338.2020.1746267] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Puig L. The safety of ixekizumab in psoriasis drug therapy. Expert Opinion on Drug Safety 2020;19:117-30. [DOI: 10.1080/14740338.2020.1709440] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Woo YR, Park CJ, Kang H, Kim JE. The Risk of Systemic Diseases in Those with Psoriasis and Psoriatic Arthritis: From Mechanisms to Clinic. Int J Mol Sci 2020;21:E7041. [PMID: 32987907 DOI: 10.3390/ijms21197041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
23 Liu WC, Liu HE, Kao YW, Qin L, Lin KC, Fang CY, Tsai LL, Shia BC, Wu SY. Definitive radiotherapy or surgery for early oral squamous cell carcinoma in old and very old patients: A propensity-score-matched, nationwide, population-based cohort study. Radiother Oncol 2020;151:214-21. [PMID: 32866564 DOI: 10.1016/j.radonc.2020.08.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
24 Holmannova D, Borsky P, Andrys C, Hamakova K, Cermakova E, Poctova G, Fiala Z, Smejkalova J, Blaha V, Borska L. Chromosomal Aberrations and Oxidative Stress in Psoriatic Patients with and without Metabolic Syndrome. Metabolites 2022;12:688. [PMID: 35893255 DOI: 10.3390/metabo12080688] [Reference Citation Analysis]
25 Barbieri JS, Wang S, Ogdie AR, Shin DB, Takeshita J. Age-appropriate cancer screening: A cohort study of adults with psoriasis prescribed biologics, adults in the general population, and adults with hypertension. J Am Acad Dermatol 2021;84:1602-9. [PMID: 33470207 DOI: 10.1016/j.jaad.2020.10.045] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 Abramczyk R, Queller JN, Rachfal AW, Schwartz SS. Diabetes and Psoriasis: Different Sides of the Same Prism. Diabetes Metab Syndr Obes. 2020;13:3571-3577. [PMID: 33116708 DOI: 10.2147/dmso.s273147] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
27 Karmacharya P, Shahukhal R, Ogdie A. Risk of Malignancy in Spondyloarthritis: A Systematic Review. Rheum Dis Clin North Am 2020;46:463-511. [PMID: 32631600 DOI: 10.1016/j.rdc.2020.04.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
28 Pillai A, Adilbay D, Matsoukas K, Ganly I, Patel SG. Autoimmune disease and oral squamous cell carcinoma: A systematic review. J Oral Pathol Med 2021. [PMID: 34145639 DOI: 10.1111/jop.13218] [Reference Citation Analysis]
29 Bu J, Ding R, Zhou L, Chen X, Shen E. Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review. Front Immunol 2022;13:880201. [PMID: 35757712 DOI: 10.3389/fimmu.2022.880201] [Reference Citation Analysis]
30 Loft ND, Vaengebjerg S, Skov L. Cancer risk in patients with psoriasis: should we be paying more attention? Expert Review of Clinical Immunology 2020;16:479-92. [DOI: 10.1080/1744666x.2020.1754194] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
31 van de Kerkhof PCM. The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis. Br J Dermatol 2021;185:879. [PMID: 34402525 DOI: 10.1111/bjd.20624] [Reference Citation Analysis]
32 Jahrami H, Saif Z, AlHaddad M, Faris MA, Hammad L, Ali B. Assessing dietary and lifestyle risk behaviours and their associations with disease comorbidities among patients with depression: A case-control study from Bahrain. Heliyon 2020;6:e04323. [PMID: 32637706 DOI: 10.1016/j.heliyon.2020.e04323] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Pezzolo E, Naldi L. Epidemiology of major chronic inflammatory immune-related skin diseases in 2019. Expert Review of Clinical Immunology 2020;16:155-66. [DOI: 10.1080/1744666x.2020.1719833] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
34 Liu WC, Liu HE, Kao YW, Qin L, Lin KC, Fang CY, Tsai LL, Shia BC, Wu SY. Definitive intensity-modulated radiotherapy or surgery for early oral cavity squamous cell carcinoma: Propensity-score-matched, nationwide, population-based cohort study. Head Neck 2021;43:1142-52. [PMID: 33314548 DOI: 10.1002/hed.26575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Kishimoto M, Komine M, Sashikawa-Kimura M, Ansary TM, Kamiya K, Sugai J, Mieno M, Kawata H, Sekimoto R, Fukushima N, Ohtsuki M. STAT3 Activation in Psoriasis and Cancers. Diagnostics (Basel) 2021;11:1903. [PMID: 34679602 DOI: 10.3390/diagnostics11101903] [Reference Citation Analysis]